Ertapenem Hospira (ertapenem)
Generic
- Region
- 🇪🇺 EU
- Active substance
- ertapenem
- Company
- Hospira UK Limited
- Status
- Application withdrawn
- Therapeutic area
- Bacterial Infections
- Designations
- Generic
- Application
- EMEA/H/C/004080
- ATC
- J01DH03
- Official record
- www.ema.europa.eu
Indication
Treatment of bacterial infections and prophylaxis of surgical site infection following elective colorectal surgery.
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Ertapenem SUN Authorised · SUN Pharmaceutical Industries (Europe) B.V.
- 🇪🇺 Invanz Authorised · Merck Sharp & Dohme B.V.
Follow Ertapenem Hospira
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.